User profiles for Zhiyong Ma
 | Ma Zhiyong(马志勇)State Key Laboratory of Organic-Inorganic Composites，BUCT; TU/e; Peking University Verified email at mail.buct.edu.cn Cited by 2958 |
Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia
…, Q Zhao, Y Xiong, L Deng, S Song, Z Ma… - The Journal of …, 2020 - academic.oup.com
Background In December 2019, novel coronavirus (SARS-CoV-2) pneumonia (COVID-19)
was reported in Wuhan and has since rapidly spread throughout China. We aimed to clarify …
was reported in Wuhan and has since rapidly spread throughout China. We aimed to clarify …
[PDF][PDF] Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
…, S Gao, K Liang, M Luo, T Chen, S Song, Z Ma… - Clin infect dis, 2020 - alatorax.org
Background: Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19)
occurred in Wuhan, and rapidly spread throughout China. This study aimed to …
occurred in Wuhan, and rapidly spread throughout China. This study aimed to …
Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses
Z Ma, E Zhang, D Yang, M Lu - Cellular & molecular immunology, 2015 - nature.com
It is well accepted that adaptive immunity plays a key role in the control of hepatitis B virus (HBV)
infection. In contrast, the contribution of innate immunity has only received attention in …
infection. In contrast, the contribution of innate immunity has only received attention in …
Stimuli‐responsive purely organic room‐temperature phosphorescence materials
L Huang, C Qian, Z Ma - Chemistry–A European Journal, 2020 - Wiley Online Library
This Minireview summarizes the recent progress of stimuli‐responsive purely organic
phosphorescence materials. Organic phosphorescence is closely related to the intermolecular …
phosphorescence materials. Organic phosphorescence is closely related to the intermolecular …
A 90-nm logic technology featuring strained-silicon
…, C Kenyon, J Klaus, K Kuhn, Z Ma… - … on electron devices, 2004 - ieeexplore.ieee.org
A leading-edge 90-nm technology with 1.2-nm physical gate oxide, 45-nm gate length,
strained silicon, NiSi, seven layers of Cu interconnects, and low-/spl kappa/ CDO for high-…
strained silicon, NiSi, seven layers of Cu interconnects, and low-/spl kappa/ CDO for high-…
[HTML][HTML] The occurrence and contamination level of ochratoxin A in plant and animal-derived food commodities
Ochratoxin A (OTA) is a highly toxic mycotoxin and poses great threat to human health. Due
to its serious toxicity and widespread contamination, great efforts have been made to …
to its serious toxicity and widespread contamination, great efforts have been made to …
Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: a single-centered, retrospective study
TL Chen, Z Dai, P Mo, X Li, Z Ma, S Song… - The Journals of …, 2020 - academic.oup.com
Background In December 2019, the coronavirus disease 2019 (COVID-19) emerged in
Wuhan city and spread rapidly throughout China and the world. In this study, we aimed to …
Wuhan city and spread rapidly throughout China and the world. In this study, we aimed to …
A logic nanotechnology featuring strained-silicon
…, G Glass, T Hoffman, J Klaus, Z Ma… - IEEE Electron …, 2004 - ieeexplore.ieee.org
Strained-silicon (Si) is incorporated into a leading edge 90-nm logic technology . Strained-Si
increases saturated n-type and p-type metal-oxide-semiconductor field-effect transistors (…
increases saturated n-type and p-type metal-oxide-semiconductor field-effect transistors (…
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302) …
C Zhou, Z Wang, Y Sun, L Cao, Z Ma, R Wu… - The Lancet …, 2022 - thelancet.com
Background PD-1 inhibitor plus chemotherapy had been shown to be an effective first-line
treatment for patients with metastatic non-small-cell lung cancer (NSCLC). However, there …
treatment for patients with metastatic non-small-cell lung cancer (NSCLC). However, there …
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in …
…, C Huang, A Liu, N Yang, Y Gong, C Zhu, Z Ma… - The Lancet …, 2022 - thelancet.com
Background A substantial proportion of patients with unresectable stage III non-small-cell
lung cancer (NSCLC) cannot either tolerate or access concurrent chemoradiotherapy, so …
lung cancer (NSCLC) cannot either tolerate or access concurrent chemoradiotherapy, so …
